Korean J Fam Med.  2017 Sep;38(5):291-295. 10.4082/kjfm.2017.38.5.291.

Carbohydrate-Deficient Transferrin as a Biomarker for Screening At-Risk Drinking in Elderly Men

Affiliations
  • 1Department of Family Medicine, Research Institute for Medical Sciences, Chungnam National University School of Medicine, Daejeon, Korea. jskim@cnuh.co.kr

Abstract

BACKGROUND
Carbohydrate-deficient transferrin (CDT) is a useful biomarker to identify excessive alcohol consumption; however, few studies have validated the %CDT cut-off value in elderly men. This study estimated the optimal %CDT cut-off value that could identify excessive alcohol consumption in men aged ≥65 years.
METHODS
This retrospective study included 120 men who visited the department of family medicine at Chungnam National University Hospital for health check-up between January 2010 and August 2013. At-risk drinking included heavy- and binge drinking. Heavy drinking was defined as more than seven standard drinks/wk, and binge drinking was defined as more than three standard drinks/d. The cut-off %CDT values for at-risk drinking were determined using receiver operating characteristic (ROC) curves.
RESULTS
Based on the ROC curves, the optimal %CDT cut-off values in ≥65-year-old men were 1.95% for at-risk drinking, 1.81% for heavy drinking, and 2.07% for binge drinking. The sensitivity, specificity, and positive and negative predictive values were 58.7%, 83.6%, 69.2%, and 76.2% for at-risk drinking, respectively. The AUROC were >0.7 for all three evaluated cut-offs.
CONCLUSION
Our results suggest that the %CDT cut-off value for at-risk drinking in elderly Korean men (≥65 years) should be readjusted to a lower value of 1.95%.

Keyword

Transferrin; Biomarkers; Drinking; Screening

MeSH Terms

Aged*
Alcohol Drinking
Binge Drinking
Biomarkers
Chungcheongnam-do
Drinking*
Humans
Male
Mass Screening*
Retrospective Studies
ROC Curve
Sensitivity and Specificity
Transferrin*
Biomarkers
Transferrin
Full Text Links
  • KJFM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr